Background:Delayed labour progress is common in nulliparous women, often leading to caesarean section despite augmentation of labour with synthetic oxytocin. Background: High- or low-dose oxytocin can be used for augmentation of delayed labour, but evidence for promoting high dose is weak. Dystocia is the leading indication for primary caesarean section. Augmentation of labour with oxytocin is a frequent intervention in modern obstetric practice. Oxytocin has been demonstrated to increase the frequency and intensity of uterine contractions when spontaneous uterine contraction is inadequate and the progress of labour is slow. Oxytocin protocols can be categorized as high-dose or low-dose protocols depending on the initial dose and the amount and rate of sequential increases. Despite the frequency with which oxytocin is used in clinical practice, there is little consensus regarding the optimal dose of oxytocin for labour augmentation. This study aims to compare the efficacy and safety of high and low dose oxytocin on augmentation of labour and to study maternal and fetal morbidity and mortality